See every side of every news story
Published loading...Updated

Pharma companies worried about threat of tariffs

  • Pharmaceutical companies expressed concerns about potential tariffs impacting investment in Europe, as stated in a letter to Ursula von der Leyen.
  • These concerns arose because new regulations and the trade war between the US and EU create a 'crisis' for the pharmaceutical sector.
  • Executives from companies like Pfizer and AstraZeneca warned about possible redirection of up to €100 billion in investments away from Europe.
  • IPHA's Oliver O'Connor stated that pharmaceutical investment is "very long-term and costly", highlighting concerns about tariffs.
  • The potential diversion of investments suggests a possible industry shift, with funds potentially moving to the US or other fast-growing economies.
Insights by Ground AI
Does this summary seem wrong?

9 Articles

All
Left
2
Center
3
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

TFD broke the news in on Wednesday, April 16, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.